High levels of estrogen, androgen and prolactin were associated with an increased risk of developing invasive breast cancer after menopause, U.S. researchers reported. The findings suggest that adding hormone levels to markers already routinely considered could significantly improve breast cancer risk prediction models, study author Shelley Tworoger said.

Related Summaries